AJP On Other Exchanges
Symbol
Exchange
Natl India

ajanta pharma ltd (AJP) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AJANTA PHARMA LTD (AJP)
\

Related News

No related news articles were found.

ajanta pharma ltd (AJP) Related Businessweek News

No Related Businessweek News Found

ajanta pharma ltd (AJP) Details

Ajanta Pharma Limited, a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers products in various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory, general and health products, dermatology, ophthalmology, pain management, and others. The company provides its products in various dosage forms, including tablets, capsules, powders, ointments, eye drops, and cough syrups. The company sells the branded generics in Asia, Africa, the Middle East, and the Commonwealth of Independent States; and the generics in the United States. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Founded in 1973

ajanta pharma ltd (AJP) Top Compensated Officers

MD & Executive Director
Total Annual Compensation: 44.1M
Joint MD & Director
Total Annual Compensation: 44.1M
Chief Financial Officer
Total Annual Compensation: --
Executive Vice Chairman of the Board
Total Annual Compensation: 19.1M
Assistant VP of Legal & Company Secretary
Total Annual Compensation: --
Compensation as of Fiscal Year 2018.
ajanta pharma ltd
Ajanta Pharma Limited Recommends Final Dividend for the Year Ended 31 March 2019

Ajanta Pharma Limited announced that at its board meeting held on 30 April 2019, recommended that interim dividend of INR 9 per share declared at Board meeting held on 31 October 2018 be considered as final dividend for the year ended 31 March 2019.

Ajanta Pharma Limited Reports Audited Consolidated and Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2019

Ajanta Pharma Limited reported audited consolidated and standalone earnings results for the fourth quarter and year ended March 31, 2019. For the quarter, on consolidated basis, the company reported total income of INR 5,167.9 million compared to INR 5,355.5 million a year ago. Profit for the period was INR 888.9 million compared to INR 944.9 million a year ago. Basic earnings per share was INR 10.10 compared to INR 10.74 a year ago. For the year, on consolidated basis, the company reported total income of INR 20,764.5 million compared to INR 21,550.2 million a year ago. Profit for the period was INR 3,869.7 million compared to INR 4,686.4 million a year ago. Basic earnings per share was INR 43.97 compared to INR 53.26 a year ago. Diluted earnings per share was INR 43.96 compared to INR 53.25 a year ago. For the quarter, on standalone basis, the company reported total income of INR 4,167.2 million compared to INR 4,686.0 million a year ago. Profit for the period was INR 413.7 million compared to INR 785.0 million a year ago. Basic earnings per share was INR 4.70 compared to INR 8.92 a year ago. For the year, on standalone basis, the company reported total income of INR 18,747.7 million compared to INR 19,034.6 million a year ago. Profit for the period was INR 3,917.6 million compared to INR 4,275.2 million a year ago. Basic earnings per share was INR 44.51 compared to INR 48.59 a year ago.

Ajanta Pharma Limited to Report Q4, 2019 Results on Apr 30, 2019

Ajanta Pharma Limited announced that they will report Q4, 2019 results on Apr 30, 2019

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

AJP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AJP.
View Industry Companies
 

Industry Analysis

AJP

Industry Average

Valuation AJP Industry Range
Price/Earnings 20.8x
Price/Sales 3.9x
Price/Book 3.6x
Price/Cash Flow 17.4x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AJANTA PHARMA LTD, please visit www.ajantapharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.